concept

LNK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about LNK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

29Connections

0Hypotheses

0Analyses

20Outgoing

9Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	LNK
Key Genes/Proteins	CBL, GPX4, Hnrnpa2B1, HNRNPA2B1
Related Diseases	dopaminergic neuron vulnerability, Dopaminergic neuron vulnerability, motor impairment
Related Pathways	ferroptosis

Pathway Diagram

graph TD
    LNK[LNK]
    LNK -->|interacts| CBL[CBL]
    LNK -->|regulates| Dopaminergic_Neurodegeneration[Dopaminergic Neurodegeneration]
    LNK -->|mediates| Dopaminergic_neuron_vulnerabil[Dopaminergic neuron vulnerability]
    LNK -->|regulates| HNRNPA2B1[HNRNPA2B1]
    LNK -->|regulates| Dopaminergic_Neurons[Dopaminergic Neurons]
    LNK -->|exacerbates| Ferroptosis[Ferroptosis]
    LNK -->|contributes to| dopaminergic_neuron_vulnerabil[dopaminergic neuron vulnerability]
    LNK -->|promotes| Hnrnpa2B1[Hnrnpa2B1]
    LNK -->|causes| dopaminergic_neuron[dopaminergic neuron]
    LNK -->|involved_in| therapeutic_target[therapeutic_target]
    lifitegrast[lifitegrast] -->|targets| LNK
    Lifitegrast[Lifitegrast] -->|modulates| LNK
    CBL -->|activates| LNK
    HNRNPA2B1 -->|activates| LNK
    GPX4[GPX4] -->|regulates| LNK
    benchmark_ot_ad_answer_key_LNK[benchmark_ot_ad_answer_key:LNK] -->|data_in| LNK

Outgoing (20)

Target	Relation	Type	Str
benchmark_ot_ad_answer_key:LNK	data_in	dataset_row	0.00
Dopaminergic Neurodegeneration	regulates	process	0.95
CBL	interacts_with	protein	0.95
Dopaminergic neuron vulnerability	mediates	phenotype	0.91
HNRNPA2B1	regulates	protein	0.90
Parkinson Disease	associated_with	disease	0.90
Dopaminergic Neurons	regulates	cell_type	0.90
Ferroptosis	exacerbates	process	0.89
Parkinson's disease	associated_with	disease	0.88
dopaminergic neuron vulnerability	contributes_to	phenotype	0.88
therapeutic_target	involved_in	phenotype	0.85
Hnrnpa2B1	promotes	protein	0.85
dopaminergic neuron	causes	cell_type	0.85
Parkinson's Disease	risk_factor_for	disease	0.85
Motor Impairment	correlates_with	phenotype	0.85
motor impairment	associated_with	phenotype	0.80
RNA	activates	gene	0.60
ubiquitin-proteasome	participates_in	pathway	0.60
neurodegeneration	associated_with	disease	0.60
ferroptosis	participates_in	pathway	0.60

Incoming (9)

Source	Relation	Type	Str
benchmark_ot_ad_answer_key:LNK	data_in	dataset_row	0.00
lifitegrast	targets	drug	0.85
Lifitegrast	modulates	drug	0.85
lifitegrast	binds	drug	0.75
CBL	activates	gene	0.60
HNRNPA2B1	activates	gene	0.60
CBL	regulates	gene	0.60
GPX4	regulates	gene	0.60
HNRNPA2B1	regulates	gene	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning LNK in their description or question text

No additional research found